Delivery Order SPE2DB22D1106-SPE2DB24FFCA3
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML pharmaceutical products. The contract has a total potential value of $8,961.84 and a completion date of February 15, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order for the pharmaceutical product EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML. The $6,379.26 Firm Fixed Price contract is funded by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support. The contract has an ultimate completion date of June 18, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, to the Department of Defense (DoD) and other government agencies. The contract, valued at $1,685.84, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,651.87 firm fixed-price delivery order is for the provision of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for various medical applications. The contract has an ultimate completion date of March 11, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The $8,751.65 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency. This contract does not have a set-aside designation. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The award is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $10,392.48 and a completion date of June 25, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $14,769.56 firm-fixed-price delivery order is for the supply of 4565778812 EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, with a period of performance through September 13, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $20,392.09, is a firm fixed-price delivery order for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML pharmaceutical products. The contract has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML medical supplies. The single-award, Firm Fixed Price Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a potential value of $3,231.78. The contract has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside. The contract is...